Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Withdrawn 1Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 19Genitourinary 16Breast 15Sarcoma 4Head & Neck 3Tumor-Agnostic 2Other solid neoplasm 2Gynecologic 2CNS 2Gastrointestinal 1Endocrine 1

Conditions

Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1Breast Neoplasms, Male 1Breast Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

telotristat ethyl 4lutetium Lu 177 dotatate 43-Iodobenzylguanidine 3vandetanib 2pasireotide 2gallium Ga 68 dotatate 2Temozolomide 2Octreotide 2Biological Therapy 2177Lu-octreotide, DOTA(0)-Tyr(3)- 2veliparib 1vatalanib 1trametinib 1pembrolizumab 1lanreotide 1fosbretabulin 1farletuzumab 1dabrafenib 1combretastatin 1ceritinib 1antineoplaston AS 2-1 1antineoplaston A10 1Tretinoin 1Tranexamic Acid 1Solutions 1Saline Solution 1Panitumumab 1Paclitaxel 1Microarray Analysis 1Isotretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Docetaxel × Endocrine × Clear all
NCT00937417 2017-04-24

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

SWOG Cancer Research Network

Phase 1 Withdrawn
BreastCNSEndocrineGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡